Steffen Lang
Steffen Lang is the President of Operations at Novartis, a leading global healthcare company based in Switzerland. He is known for his strategic focus on enhancing production efficiency and automation within the pharmaceutical industry. Recently, he was in the news for announcing Novartis's plans to stop the production of tablets and capsules at their Stein facility in Aargau by 2027, which may lead to a reduction of approximately 550 jobs, while also outlining plans for significant investments in production capabilities in the U.S.
Not in the pool (under ¢1).
Recent news mentions
Steffen Lang is the global production head of Novartis who commented on the company's competitiveness in Switzerland.
Neues Werk von BMS in Boudry erhält Konkurrenz aus USA
Switzerland· 2026-05-28
Steffen Lang is a member of the board of the Swiss company and highlighted the importance of the new production facility for Novartis.
Odprtje tovarne v Mengšu velik mejnik tudi za Novartis
Slovenia· 2026-03-04
Steffen Lang is the global production manager of Novartis.
Untergangsstimmung ist fehl am PlatzSwitzerland· 2025-12-18
Steffen Lang is quoted in the media release regarding Novartis's production plans.
Novartis will bis 2027 rund 550 Stellen in der Schweiz abbauenSwitzerland· 2025-11-25